Skip to content

Bill Schiffner

Some relatively easy industry predictions

Some relatively easy industry predictions

The new year has been under way for about a month now, and speculation about the upcoming 12 months already abounds. Not to be left at the starting gate, here’s a look from Chain Drug Review’s headquarters into what just might happen between now and December 31 and what will remain anyone’s guess.

Automation: The future of pharmacy

Automation: The future of pharmacy

The global pharmacy automation market was valued at $5.60 billion in 2022 and is expected to grow at a CAGR (compound annual growth rate) of 8.02% from 2022 to 2030. This estimated growth makes it possible to forecast $10.4 billion in revenues by 2030 for this market.

Donigan’s exit raises questions

Donigan’s exit raises questions

The new year has gotten off with a stunning development, at least for those with no inside knowledge of chain drug retailing. Heyward Donigan, Rite Aid’s chief executive, announced she is leaving the company she joined three years ago.